I am excited by your letter. The board is excited to consider the suggestion. Employees are excited.
The mailman who gave us the letter is excited. You know what, everybody is excited. I hope shareholders will be excited as much as us.
The same sheet as before and no activist with 3m shares can move a needle.
When Armistice gets 15m shares then it may get some attention.
Losers like cigan1956 are wasting their times and breath. They get paid more if they clean Raj's bathroom.
Anyway, no one at Spectrum gives it a rat #$%$ Armistice bught a few million shares below $5 and it will sell with profit and goes away. The poor new traders who bought recently must be nervous. Raj will not give up anything. No one gives up anything.
$160m for this year?
That was before significant loss of revenue which you and your airhead friend Joe were saying $200m.
Significant loss of revenue means zero to 10% of previous revenue.
Didn't you see how Raj voice was shaky when he was talking about Fusilev. You need to get over this matter.
Now, SPPI is diversified with 5 drugs, each producing $2m or less per quarter and all have negative growth.
Longs should buy buy an orange jumpsuit before earnings.
You can buy it thru Ebay or AMZN.
Still time to avoid orange shirt.
Wow, you switched your sentiment after last dip that marked a new 52-week low.
Is that all you want? SPPI is the same or worse than a few weeks ago.
How about a new 52-week low after the earnings?
Feb 23, 2015 : $5.65 *** 52-week low
Apr 08, 2015 : $5.58 *** 52-week low
Apr 30, 2015 : $5.45 *** 52-week low
May xx, 2015 : $5.3x *** 52-week low
Welcome to the world of reality. No matter how much you are pumping, the stock is going lower and lower.
Shorting is legal as much as going long. If a short wins, it is as good as a long. Shorting is not manipulation. A however, a stock can be manipulated by both shorts and longs.
When a stock has weak fundamentals, pro go short so a stock reflects the weakness. From investors point of view, it should not matter short or long as long as it profits the investor.
SPPI is a weak stock with 5 approved drugs since 4 out of five have negative growth and very small revenue. This fact increases manufacturing and marketing costs for these small drugs. Fusilev is the only SPPI drug that has shown growth in past few quarters but guess what will happen to Fusilev now that Sandoz came up with generic Fusilev and court ordered in favor of Sandoz? SPPI is toast. If you want to talk about pipeline or management, good luck. First, show me the money. You know a good year from its spring. Unfortunately, SPPI negatives are numerous and smart money is shorting the stock.
Yeh, now all SPPI problems have poofed with help of yahoo. Raj will say free shares are Yekee.
Recycled drugs won't bring any profit.
SPPI advertizes for 5 approved drugs that are not as good as one average drug.
They either have no growth or are challenged by other companies like Sandoz.
The pipeline is not any better than the approved drugs especially in hands of Raj and his marketing style.